SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-091865
Filing Date
2021-03-24
Accepted
2021-03-24 07:00:31
Documents
14
Period of Report
2021-03-24
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d119783d8k.htm   iXBRL 8-K 25099
2 EX-99.1 d119783dex991.htm EX-99.1 19634
6 GRAPHIC g119783img001.jpg GRAPHIC 2572
  Complete submission text file 0001193125-21-091865.txt   181842

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA krys-20210324.xsd EX-101.SCH 3075
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE krys-20210324_lab.xml EX-101.LAB 18887
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krys-20210324_pre.xml EX-101.PRE 11863
7 EXTRACTED XBRL INSTANCE DOCUMENT d119783d8k_htm.xml XML 3446
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38210 | Film No.: 21766536
SIC: 2836 Biological Products, (No Diagnostic Substances)